Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.700
+0.050 (3.03%)
At close: May 22, 2026, 4:00 PM EDT
1.730
+0.030 (1.76%)
After-hours: May 22, 2026, 7:56 PM EDT
Autolus Therapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Autolus Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $8.71. The average 1-year stock price forecast is 412.35% higher than the current stock price, while the lowest is $5.00 (+194.12%) and the highest is $11 (+547.06%).
Price Target: $8.71 (+412.35%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Autolus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 2 | 2 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +488.24% | May 14, 2026 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +488.24% | Apr 9, 2026 |
| Mizuho | Mizuho | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +488.24% | Mar 31, 2026 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +488.24% | Mar 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +429.41% | Feb 17, 2026 |
Financial Forecast
Revenue This Year
132.96M
from 75.39M
Increased by 76.37%
Revenue Next Year
216.12M
from 132.96M
Increased by 62.55%
EPS This Year
-0.93
from -1.08
EPS Next Year
-0.64
from -0.93
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 154.4M | 290.9M | ||||||
| Avg | 133.0M | 216.1M | ||||||
| Low | 119.3M | 147.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 104.7% | 118.8% | ||||||
| Avg | 76.4% | 62.5% | ||||||
| Low | 58.2% | 10.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.59 | -0.45 | ||||||
| Avg | -0.93 | -0.64 | ||||||
| Low | -1.21 | -0.86 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.